Regenicin, Inc. (RGIN) Director Attends the World Stem Cells and Regenerative Medicine Congress 2011
Regenicin, Inc. just announced that Dr. Craig Eagle, who sits on the Regenicin Board of Directors, attended The World Stem Cells and Regenerative Medicine Congress 2011 in an effort to further Regencin's push towards obtaining FDA approval for the commercial sale of its first product candidate. The World Stem Cells and Regenerative Medicine Congress is recognized for offering a senior director-level, interactive conference experience. Speakers and panelists include industry leaders from throughout Europe, North America and Asia. The World Stem Cells and Regenerative Medicine Congress is Europe's most progressive strategic conference where ideas, intelligence and relationships really make a difference.…